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Summary
Compulsive overconsumption of reward characterizes dis-
orders ranging from binge eating to drug addiction. Here,
we provide evidence that enkephalin surges in an anterome-
dial quadrant of dorsal neostriatum contribute to generating
intense consumption of palatable food. In ventral striatum,
mu opioid circuitry contributes an important component of
motivation to consume reward [1–4]. In dorsal neostriatum,
mu opioid receptors are concentrated within striosomes
that receive inputs from limbic regions of prefrontal cortex
[5–13]. We employed advanced opioid microdialysis tech-
niques that allow detection of extracellular enkephalin
levels. Endogenous >150% enkephalin surges in anterior
dorsomedial neostriatum were triggered as rats began to
consume palatable chocolates. In contrast, dynorphin levels
remained unchanged. Furthermore, a causal role for mu
opioid stimulation in overconsumption was demonstrated
by observations that microinjection in the same anterior
dorsomedial quadrant of a mu receptor agonist ([D-Ala2,
N-MePhe4, Gly-ol]-enkephalin; DAMGO) generated intense
>250% increases in intake of palatable sweet food (without
altering hedonic impact of sweet tastes). Mapping by ‘‘Fos
plume’’ methods confirmed the hyperphagic effect to be
anatomically localized to the anteromedial quadrant of the
dorsal neostriatum, whereas other quadrants were relatively
ineffective. These findings reveal that opioid signals in ante-
romedial dorsal neostriatum are able to code and cause
motivation to consume sensory reward.
Results and Discussion
Dorsal neostriatum has been traditionally viewed to mediate
movement and habits [9, 14–16] and to respond to learned
cues [17], whereas ventral striatum is known to generate
reward and motivation to consume incentives (in large part
mediated by opioid circuitry) [2, 18]. Dorsal striatum recently
has also become implicated in reward-related functions [19–
24], and here we report that opioid signaling in an extremely
dorsal region of neostriatum contributes to generating intense
motivation to overconsume palatable food reward. In dorsal
neostriatum, mu opioid receptors are localized mainly in
‘‘patch’’ or ‘‘striosome’’ compartments [5, 7]. Patches or strio-
somes in neostriatum receive converging inputs from limbic
regions of prefrontal cortex, including from orbitofrontal, pre-
limbic, and anterior cingulate regions [5, 6, 9–13]. We focused
here on the medial region of dorsal neostriatum, which has*Correspondence: agdife@umich.edubeen implicated by previous studies in processing value of
reward [25].
In short, our microinjection results revealed that exogenous
mu opioid stimulation by [D-Ala2, N-MePhe4, Gly-ol]-enkeph-
alin (DAMGO) microinjection into the anteromedial dorsal neo-
striatum potently enhanced consumption of palatable M&M
chocolates, more than doubling total M&M intake. This hyper-
phagic effect was specifically localized within the anterome-
dial quadrant of the dorsal neostriatum (DAMGO = 251%
average increase over vehicle levels). Accordingly, our micro-
dialysis study of that same anteromedial quadrant of dorsal
neostriatum found that endogenous enkephalin levels rose
to 150% of baseline when rats were suddenly allowed to eat
chocolates. These endogenous and exogenous results are
described in detail below.
Endogenous Enkephalin Release
Microdialysis probes implanted in anteromedial dorsal neo-
striatum measured extracellular levels of endogenous striatal
opioid peptides: enkephalin (likely released from ‘‘indirect
path’’ neurons that also express dopamine D2 receptors)
and dynorphin (likely released from ‘‘direct path’’ neurons
that express dopamine D1 receptors). Enkephalin and dynor-
phin were measured first during a normal (‘‘quiet’’) behavioral
state in mildly hungry rats before any meal to establish a base-
line, and next when a large quantity of palatable chocolate
candies (M&Ms) were suddenly presented. Opportunity to
eat chocolate M&Ms evoked avid consumption, averaging 10
M&Ms in 20 min (z10 g), and elicited an immediate increase
in endogenous levels of met-enkephalin and leu-enkephalin,
reaching an elevation of >150% over premeal baseline (base-
line6SEM:met-enkephalin = 2.616 0.56 pM, leu-enkephalin =
2.32 6 0.30 pM; Friedman’s test, p < 0.01; baseline = 100%;
Figures 1 and 2A). Enkephalin levels remained elevated
throughout the roughly 20–40 min period during which each
rat continued to eat and then began to decline as rats slowed
and gradually ceased eating, typically returning fully back to
baseline within the next 40 min (first baseline versus last
sample, Wilcoxon’s test, not significant [NS]).
In contrast to enkephalin levels, dynorphin levels failed to
increase during eating and instead remained unchanged
throughout the meal (Friedman’s test, p > 0.1; Figure 2B).
Therefore, only enkephalin in the anteromedial quadrant of
dorsal neostriatum became dynamically elevated during con-
sumption of palatable food.
Enkephalin surges did not seem to be a consequence of
mere motor activity. Enkephalin changes were measured
during ‘‘motor’’ periods when the rat performed noningestive
active movements, such as oromotor gnawing of plastic or
wood objects, spontaneous body grooming, or locomotion
(walking and/or rearing) in the absence of food (Figure 2C).
During these noningestive activities, enkephalin levels never
increased (Friedman’s test, p = 1, NS), suggesting that the
increase described above in the same rats in response to
eating chocolates was not due simply to the motoric produc-
tion of active movements involved in eating. In contrast,
enkephalin levels did increase when M&Ms were presented
and eaten, compared to the previous periods when rats
Figure 1. Endogenous Extracellular Opioid Pep-
tides in Response to Palatable Food Con-
sumption
Extracellular enkephalin levels surged when rats
began to eat milk chocolate M&Ms. Onset of
eating coincided with a robust increase in extra-
cellular enkephalin (met and leu), which remained
sustained during eating and gradually tapered
off as eating declined. The magnitude of the
enkephalin increase in individuals correlated
with their latency to eat their first M&M: higher
enkephalin increase for the fastest eaters. The
correlation between faster speed to start eating
and higher enkephalin also remains significant
if the highest outlier individual (upper right of
inset) is removed (Spearman’s rho = 20.85, p =
0.013, 95% CI [21, 20.4]). *p < 0.05. Error bars
represent SEM.
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p = 0.023), again suggesting that enkephalin reflected more
than simply the occurrence of ongoing motor activities (Fig-
ure 2C). Therefore, it appears that enkephalin increased
specifically with onset of the reward experience of eating
palatable chocolates, remained elevated during eating, and
declined soon after.
Finally, we found that the magnitude of the enkephalin
surge in each rat correlated with that individual’s speed or
latency to begin consuming its first M&M (Spearman’s rho =
20.90, p = 0.002, 95% confidence index [CI] [21, 20.392];
Figure 1 inset): the faster a rat started eating, the higher its
relative increase in enkephalin levels. This correlation raised
the possibility that anteromedial dorsal neostriatum opioid
levels might contribute a motivational ‘‘eat now’’ command.
That causal hypothesis was tested further in themicroinjection
study below.
Exogenous Mu Stimulation of Intense Eating
We found that DAMGO microinjection in dorsal neostriatum
stimulated more intense eating of chocolates in nondeprived
rats, but depending on precise site or quadrant. Sites within
the anteromedial quadrant of dorsal neostriatum produced
by far the most intense increases of >250% intake of M&Ms
(t(18) = 5.1, p < 0.001, 95% CI [9.96, 4.15], Cohen’s d = 1.217
compared to vehicle control intake levels by the same rats;
Figure 3A). Anteromedial quadrant sites produced higher
elevations of eating than all other quadrants of dorsal neostria-
tum (anteromedial versus other quadrants F(1,36) = 8.44, p =
0.006, 95% CI [136, 235], Cohen’s d = 1.09). Localization of
function was further determined by mapping the causal effi-
cacy of neostriatal microinjection sites to stimulate eating,
using symbols sized to the measured radius of Fos plumes
surrounding DAMGO microinjections in dorsal neostriatum
(Fos radius reflects the anatomical spread of drug impact; Fig-
ure 3). For sites that elevated eating >250%, at least 90%of the
volume of DAMGO-induced local Fos plumeswould have been
contained entirely within the anteromedial quadrant of dorsalneostriatum. That is, DAMGO Fos
plumes were measured to have a
0.18 mm total radius (0.02 mm3 volume),
containing an inhibited small center
(0.15 mm radius, 0.016 mm3 volume
zone of halved Fos expression com-
pared to vehicle baselines) surroundedby a larger excitatory Fos sphere (0.18 mm radius, 0.02 mm3
volume zone of doubled Fos expression over normal baseline;
the center/surround Fos opposition possibly reflects recip-
rocal local inhibitory connections between the two zones; Fig-
ure 3A inset). These plume measurements allow confidence
that the intense overconsumption was generated by DAMGO
stimulation of anteromedial dorsal neostriatum rather than by
diffusion to other regions of neostriatum, ventral striatum, or
nucleus accumbens.
For sites in the highly effective anteromedial quadrant of
dorsal neostriatum, most rats ate over 17 g of M&Ms, equal
to about 5% of their 300 g body weight (Figure 3A). That level
of elevated consumption (5% of body weight) is roughly pro-
portional to a 68 kg human consuming w3.6 kg of M&Ms in
a single hour, clearly overriding normal satiety signals [1, 26].
DAMGO microinjection in this anteromedial quadrant also
made rats faster to begin to eat (in addition to making them
eat more), decreasing the latency to begin eating their first
M&M of the day (vehicle = 55.4 6 10.4 s; DAMGO = 28.7 6
4.2 s; t(25) = 2.49, p = 0.019, 95% CI [4.69, 48.85], Cohen’s d =
2.781). Faster speed to eat supports the hypothesis that mu
opioid receptor stimulation in this neostriatum region provides
a command to ‘‘eat now’’ as well as to ‘‘eat more.’’
In contrast to the anteromedial quadrant, as microinjection
sites moved posteriorly in medial dorsal neostriatum, the level
of stimulated eating gradually declined. Strong elevation of
eating was still produced at intermediate medial sites where
the diameter of Fos plumes straddled the border between an-
teromedial and posteromedial quadrants of dorsal neostria-
tum (190% increase). No significant elevation was produced
by more posterior sites fully contained within the postero-
medial quadrant (i.e., where no part of a posterior site’s Fos
plume would contact the anteromedial border; average
118%, NS).Thus, for the entire posteromedial quadrant overall,
intermediate 150% elevations of eating were found, due
mostly to the medial sites that straddled the anterior/posterior
border (t(8) = 2.52, p = 0.036, 95% CI [7.28, 0.33], Cohen’s d =
0.939). Comparing anterior versus posterior directly as entire
Figure 2. Details of Endogenous Enkephalin Surge
(A and B) Absolute concentrations of met enkephalin and leu enkephalin
are displayed in (A). In contrast, dynorphin remained relatively stable
throughout resting, eating, and other behaviors (B).
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a greater increase in intense eating than DAMGO in the poster-
omedial quadrant (t(23) = 2.21, p = 0.037, 95% CI [201.6, 6.96],
Cohen’s d = 0.85). Eating increases abruptly fell off to zero as
microinjection sites moved laterally from the anteromedial
quadrant. Anterolateral quadrant sites produced no increase
at all over vehicle levels (i.e., outside of and lateral to effective
sites in dorsomedial neostriatum; only 103%; t(9) = 0.1, p =
0.917; Figure 3A).
In contrast to mu stimulation of eating, delta opioid receptor
stimulation by [D-Pen2,5]-enkephalin (DPDPE) microinjections
failed to increase eating behavior or intake over vehicle control
levels at all sites in dorsomedial neostriatum, even in the ante-
romedial quadrant (F(1,12) = 0.4, p > 0.1; see Figure S1 available
online). Accordingly, M&M intake was much higher after mu
agonist DAMGOmicroinjection than after delta agonist DPDPE
microinjection at the same anteromedial dorsal neostriatum
sites (DAMGO = 6.31 6 1.13 g, DPDPE = 20.46 6 0.68 g;
t(36) = 5.10, p < 0.001, 95% CI [9.47, 4.09], Cohen’s d = 1.65).
This difference suggests that enkephalin may act primarily at
mu receptors in anterior dorsomedial neostriatum to stimulate
increases in consumption, rather than at delta receptors.
Furthermore, DAMGO microinjections in all areas of neo-
striatum, including the anterior dorsomedial quadrant, failed
to produce any general increases in locomotor or oromotor
activity, measured by cage crosses, rearing, grooming, or
treading behaviors; chow consumption; or wooden block
gnawing (behaviors F(5,28) = 0.151, NS; chow consumption
F(15,90) = 0.68, NS; gnawing t(4) = 2.1, NS).
Exogenous Mu Stimulation Fails to Alter Hedonic ‘‘Liking’’
for Sweetness
Finally, we used the affective taste reactivity test of orofacial
‘‘liking’’ reactions to investigate whether mu opioid enhance-
ment of motivation to eat sweet food reflected purely genera-
tion of motivation to eat (similar to opioid effects in most of
ventral striatum outside a cubic-millimeter hot spot and in
central amygdala) or additionally involved any enhancement
of hedonic impact or ‘‘liking’’ for the taste of sweet reward
(typical only of restricted hot spots in ventral striatum, ventral
pallidum, etc.) [2, 4, 27]. This measure draws on rodent affec-
tive orofacial reactions (e.g., positive tongue protrusion and lip
licking to sweetness versus aversive gapes to bitterness) that
are homologous to human infant affective facial expressions
elicited by tastes [2, 4, 28]. We tested for hedonic enhance-
ment in a standard taste reactivity test using a sucrose solution
infused directly in the mouth to control stimulus quality and
duration, and tested separately for the taste of sweet/fatty
chocolate as rats voluntarily ate 0.2 g fragments of M&Ms,
replicating the chocolate stimulus and conditions of enhanced
eating behavior [29]. Taste reactivity results of both tests
showed that DAMGO microinjections in anterior dorsomedial
neostriatum failed to enhance positive hedonic taste reactions
at all, either in response to oral infusions of 1% sucrose solu-
tion (F(3,9) = 1.875, p = 0.204; Figure 3B) or in response to
the chocolate taste of solid M&M fragments (F(3,5) = 0.175,
p = 0.91; Figure 3B). Although no increase in hedonic impact(C) Enkephalin levels did not increase during noningestive activities
involving forelimbs, body, or orofacial movements (walking, rearing, gnaw-
ing, grooming), here the ‘‘motor’’ period. Enkephalin levels are presented as
percent of ‘‘quiet.’’ Average percent of time the rats engaged in each
behavior is shown in the pie charts.
*p < 0.05. Error bars represent SEM.
Figure 3. Map of Microinjection Causation Sites of Intense Eating
(A) [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) microinjection into anterior dorsomedial neostriatum potently enhanced intake of M&M chocolate
candies (high fat and high sugar). All DAMGO-evoked eating behavior and intake changes are expressed as percent increases over vehicle-evoked control
levels measured in the same rat. A two-layer ‘‘Fos plume’’ shows the maximal spread of Fos locally surrounding DAMGO microinjections. This measured
radius was used to assign the size of symbol to the microinjection site for each behaviorally tested rat. The color of each symbol depicts the magnitude
of eating behavior stimulated by DAMGO microinjection at that site, relative to vehicle control level of the same rat. The largest increases in eating were
localized to the anteromedial quadrant of dorsal neostriatum.
(B) Taste reactivity results show that DAMGO injected into the same dorsomedial area did not increase hedonic impact of sucrose (during oral infusions) or
M&M chocolates (during voluntary eating).
*p < 0.05. Error bars represent SEM.
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Figure 4. Anatomical Circuit for Anteromedial
Dorsal Neostriatum
Neurons in patches/striosomes of the anterome-
dial dorsal neostriatum are rich in mu opioid
receptors and receive cortical inputs from limbic
areas of prefrontal cortex. Some patch/striosome
neurons that express D1 receptors make direct
projections to dopamine neurons within substan-
tia nigra. D2-expressing matrix neurons release
enkephalin that could act on mu opioid recep-
tors, especially of patch neurons, to generate
motivation to eat.
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motivation to eat in the voluntary intake test, so that the rats
doubled their consumption of chocolate over vehicle control
levels (t(5) = 15.58, 95% CI [9.90, 7.09], Cohen’s d = 2.3).
Thus, DAMGO in dorsomedial neostriatum appeared to make
rats selectively ‘‘want’’ to eat M&Ms more intensely, in the
sense of enhanced eating behavior and intake, without making
them ‘‘like’’ sweetness any more, in the sense of hedonic reac-
tions to sucrose or chocolate tastes. We note that similar
dissociations involving selective increases in ‘‘wanting’’ with-
out ‘‘liking’’ are typical of opioid stimulation at many other
brain sites, including ventral striatum (except in the hot spot
of nucleus accumbens shell) and striatal-related structures
[2, 4, 27]. This dissociation between ‘‘wanting’’ versus ‘‘liking’’
suggests that mu opioid stimulation in anterior dorsomedial
neostriatummaygenerate increasesofmotivation as a specific
psychological mechanism to drive intense eating and con-
sumption of food reward.
We acknowledge that our finding of intense overconsump-
tion produced by mu opioid stimulation in the anteromedial
dorsal neostriatum contrasts at first sight with previous
reports of relative failure to observe any increase in eating after
DAMGO microinjection in dorsal neostriatum [3, 30, 31].
However, earlier studies did not distinguish anatomically
among the four quadrants of dorsal neostriatum as defined
here and typically used placements that as a whole were
more centrally located in the dorsal half of neostriatum (i.e.,
more ventral and posterior to our eating hot spot). Our finding
of eating localization in the anteromedial quadrant of the
dorsal level may explain why studies that mixed together
different subregions failed to find eating stimulation in dorsal
neostriatum.
Other hints of dorsal neostriatum involvement in motivation
to consume reward have emerged in the past decade [19–24].
In humans, dorsal striatum activation has been reported to beelicited by palatable food and its cues in
obese binge eaters, and by cocaine and
its cues in drug addicts [20–23]. Such
dorsal striatal activations have remained
slightly ambiguous: they could be
viewed as encoding either reward moti-
vation or hedonic impact, incipient
movements, habits, cognitive process-
ing, or learned predictions. Similarly,
dorsal neostriatal neuronal activations
elicited by reward or cues have been
reported in monkeys and rodents and
have often been interpreted as reflecting
learned predictions or teaching signals
(e.g., prediction error model) [16, 17,32, 33].Our resultsmore specifically indicate that dorsal striatal
activation can participate in generating intense motivation to
overconsume a reward. Thus, the generative role shown here
might link some functions of dorsal neostriatum more closely
to the reward motivation functions of ventral striatum (nucleus
accumbens) [2, 34–36]. This also seemsconsistentwith reports
that restoring synaptic function to a region of dorsal neostria-
tum can rescue eating in an aphagic mutant mouse model
and supports the interpretation that such neostriatum-
mediated rescues may involve a motivational component [24].
The hypothesis that opioid circuitry in dorsomedial neostria-
tum participates in generating motivation to overconsume a
palatable food reward also seems concordant with its anatom-
ical wiring from limbic prefrontal cortical inputs [6, 8, 10–13]
(Figure 4). For example, corticostriatal projections to the ante-
romedial region of dorsal neostriatum (‘‘rostromedial sector of
caudate putamen’’), similar to that studied here, originate from
the prelimbic region of medial prefrontal cortex in rats [10].
Corticostriatal projections from ‘‘posterior [lateral] orbitofron-
tal/anterior insular cortex and themediofrontal prelimbic/ante-
rior cingulate cortex’’ similarly terminate in striosomes in the
medial caudate in macaques, which probably overlaps with
our eating site [6]. It is also noteworthy that direct mu opioid
stimulation of prefrontal cortex regions, via DAMGO microin-
jections in orbitofrontal and prelimbic/infralimbic (ventral ante-
rior cingulate) cortex, can stimulate eating in rats, raising the
possibility of a larger opioid-related corticostriatal circuit in-
volved in eating and motivation [37].
We speculate that opioid surges particularly within antero-
medial patches of dorsal striatummight modulate presynaptic
corticostriatal glutamate release or modulate postsynaptic
activity of eating-related neurons in striosomes that contain
muopioid receptors [38, 39]. In addition, someD1 receptor-ex-
pressing neurons in striosomes may uniquely project directly
to dopamine neurons in substantia nigra [40], which might
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generate intense motivation. Beyond the neostriatum, the
anterior dorsomedial neostriatal region described here likely
interacts with other parts of the distributed mesocorticolimbic
network involved in eating and intake, including hypothal-
amus, ventral striatum, limbic cortex, amygdala, andmesolim-
bic dopamine nuclei [1, 31, 37, 41, 42].
In conclusion, our results provide novel evidence that
enkephalin surges and mu opioid stimulation in the same
anteromedial dorsal neostriatum region contribute to signaling
the opportunity to eat a sensory reward and to causally gener-
ating increased consumption of that reward. The neostriatum-
generated increase in motivation can be powerful enough to
more than double the amount of food a rat ‘‘wants’’ to eat
yet be functionally specific enough to themotivational compo-
nent of reward, rather than the hedonic component, to not
enhance ‘‘liking’’ for the same sweet chocolate treat. Opioid
circuitry in anterior dorsomedial neostriatum could in this
way participate in normal motivations and perhaps even in
generating intense pathological levels of motivation to over-
consume reward in binge eating disorders, drug addiction,
and related compulsive pursuits.
Experimental Procedures
Summary
All experiments were conducted in accordance with protocols approved by
the University of Michigan Committee on Use and Care of Animals (UCUCA).
Rats were anesthetized and implanted with bilateral (microinjection) or
unilateral (microdialysis) chronic cannulae. Rats used for sucrose taste
reactivity received oral cannulae in addition to bilateral cannulae. After at
least 5 days of recovery, rats were habituated to the testing apparatus.
For microinjection experiments, one sham injection of vehicle was given
during habituation prior to testing. After drug microinjection, rats were
placed in the free eating apparatus and video recorded for 1 hr.
Hedonic impact was measured using the taste reactivity paradigm for the
tastes of sucrose solution or M&M chocolates. Orofacial reactions elicited
by sucrose taste (1% sucrose solution) were video recorded in a standard
taste reactivity test [2, 4]. Orofacial reactions elicited by the combined sweet
and fatty sensations of milk chocolate were video recorded in a voluntary
ingestion modification of the taste reactivity paradigm, in which the rat
was given fragments of M&Ms (0.2 g each) and allowed to eat voluntarily
and emit postprandial hedonic reactions for 6 s after each fragment (scoring
was controlled for facial visibility) [29]. All behaviors were scored offline in
slow motion by an observer blind to DAMGO/vehicle condition (frame by
frame at 1/10 speed). For more details, please refer to Supplemental Exper-
imental Procedures.
For microdialysis experiments, on test days the probe was lowered and
samples were collected every 20 min with a 0.6 ml/min flow rate. A 60 min
baseline where rats engaged in various motor and oromotor behaviors
was collected before food was introduced to the chamber. Samples were
analyzed using liquid chromatography (LC) coupled with MS3 linear ion
trap. Specificity of molecular structural information gained is high through
the use of LC-MSn. After separation by LC, molecules are transferred to
gas phase and charged by electrospray ionization for mass spectrometric
(MS) analysis. During MS3, three rounds of MS are imposed for each target
peptide. Thus, within the ion trap mass spectrometer, charged molecules
are first selected for their characteristic mass-to-charge ratio (m/z) and all
other ions are excluded from the ion trap. The trapped ions are then disso-
ciated into characteristic fragments by introduction of helium as a collision
gas. Ionic products of a specific m/z (characteristic of the target peptide)
from this reaction are then fragmented in a third stage and detected to
generate a signal. Thus, peptides are detected based on retention time,
m/z, and multiple fragmentation pathways. This method yields sequence-
specific detection.
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